Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
01 1CU Chemie Uetikon GmbH
02 1CU Chemie Uetikon GmbH (340717289)
03 1PCAS
04 1Supriya Lifescience Limited
05 1AX Pharmaceutical Corp
06 2Arevipharma GmbH
07 1B&B Pharmaceuticals, Inc.
08 1Fagron Inc
09 1Fagron Services BV
10 1Kalchem International inc
11 1LETCO MEDICAL, LLC
12 1Maithri Drugs Private Limited
13 1Medisca Inc.
14 1Pharma Source Direct, Inc.
15 1Professional Compounding Centers of America
16 1Professional Compounding Centers of America dba PCCA
17 1Spectrum Laboratory Products, Inc.
01 1Arketamine Hydrochloride
02 6KETAMINE HYDROCHLORIDE
03 3Ketamine HCl
04 8Ketamine Hydrochloride
01 1Canada
02 3France
03 2Germany
04 2India
05 2Netherlands
06 6U.S.A
07 2United Kingdom
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
NDC Package Code : 49169-1041
Start Marketing Date : 2024-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
NDC Package Code : 61281-8000
Start Marketing Date : 2013-07-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
NDC Package Code : 54382-114
Start Marketing Date : 1989-02-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
NDC Package Code : 54382-128
Start Marketing Date : 1989-08-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 10920-597
Start Marketing Date : 2013-12-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 10920-701
Start Marketing Date : 2022-01-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-0697
Start Marketing Date : 2004-09-01
End Marketing Date : 2027-04-30
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 38779-1754
Start Marketing Date : 2015-03-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0120
Start Marketing Date : 2021-06-07
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-3912
Start Marketing Date : 1997-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
63
PharmaCompass offers a list of Ketamine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ketamine Hydrochloride manufacturer or Ketamine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ketamine Hydrochloride manufacturer or Ketamine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Ketamine Hydrochloride API Price utilized in the formulation of products. Ketamine Hydrochloride API Price is not always fixed or binding as the Ketamine Hydrochloride Price is obtained through a variety of data sources. The Ketamine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone, including repackagers and relabelers. The FDA regulates 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone supplier is an individual or a company that provides 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone active pharmaceutical ingredient (API) or 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone finished formulations upon request. The 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone suppliers may include 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone API manufacturers, exporters, distributors and traders.
click here to find a list of 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone suppliers with NDC on PharmaCompass.
We have 13 companies offering 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
Get in contact with the supplier of your choice:
